Obatala Sciences Announces Commercial Launch of Its ObaCell® Obesity-on-a-Chip Service NewsDavid BodeNovember 28, 2023
Obatala Sciences licenses technology from Harvard University to advance discovery in obesity, diabetes, and cancer PressDavid BodeJune 2, 2021License, Harvard University, Adipose-on-a-chip, Diabetes, Obesity
LaCell LLC and Obatala Sciences, Inc. Announce Grant Award with the National Center for Advancing Translational Sciences (NCATS) FOR IMMEDIATE RELEASE Read More PressDavid BodeApril 25, 2019